Abstract 12350: Detection of Preclinical Hypertrophic Cardiomyopathy Mutations With Advanced Imaging: The Hypertrophic Cardiomyopathy Network (HCMNet) Study
Eunice Yang(Alaska Heart and Vascular Institute), David A. Bluemke(University of Wisconsin–Madison), Carolyn Y. Ho(Brigham and Women's Hospital), Evrim Türkbey(National Institutes of Health Clinical Center), Songtao Liu
Circulation
November 26, 2013
Cited by 0
Related Papers
Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
|Circulation|2010|2.7k
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: Proposed Modification of the Task Force Criteria
|European Heart Journal|2010|1.6k
Truncations of Titin Causing Dilated Cardiomyopathy
|New England Journal of Medicine|2012|1.5k
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy
|Circulation|2018|837